Title of article
Treatment of recurrent pterygium with topical administration of interferon alpha2b: A case report
Author/Authors
Davari، Mohammad Hossien نويسنده Birjand Atherosclerosis and Coronary Artery Research Center,Birjand University of Medical Sciences,Birjand,Iran , , Ghitasi، Hoda نويسنده Hospital Duran I Reynolds,Department of Genetic, laboratory2 Hospital Duran I Reynolds,University of Barcelona translational research,Barcelona,Spain , , Davari، Esmat نويسنده member of Research committee,Birjand University of Medical Sciences,Birjand,Iran ,
Issue Information
فصلنامه با شماره پیاپی سال 2015
Pages
3
From page
30
To page
32
Abstract
Pterygium is characterized by an elastic degeneration of the conjunctiva that extends across the limbos and invades the cornea. The recurrence rate is varied from 2580% after primary closure to 6% with free conjunctival and Iimbal grafts. Several adjunctive therapies have been investigated for recurrent pte¬rygium. This article presents a 52yearold athletic man who was seen for evaluation of a recurrent lesion in his right eye and treated with topical administration of IFN-α-2b (Intron A, Schering Plough, Kenilworth, NJ), 1 million units/mL 4 times a day as eye drops.
Keywords
Topical administration , Recurrent pterygium , Interferon alpha-2b
Journal title
Journal of Surgery and Trauma
Serial Year
2015
Journal title
Journal of Surgery and Trauma
Record number
2404482
Link To Document